aluates Reports

$ 0.0

Automative

Global GP681 Market Research Report 2026

Published Date: 2026-05-15

Report Code: QYRE-Auto-28J20142

BUY CHAPTERS

Global GP681 Market Research Report 2026

Code: QYRE-Auto-28J20142

Report

2026-05-15

Pages:102

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Qingfeng Pharmaceutical

Jiangxi Kerui Pharmaceutical

Yinxingshu Pharmaceutical

GP681 Market Size

The global GP681 market was valued at US$ 35.00 million in 2025 and is anticipated to reach US$ 191 million by 2032, at a CAGR of 8.1% from 2026 to 2032.

GP681 Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on GP681 competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

GP681 is a novel oral antiviral drug targeting influenza viruses, belonging to the class of cap‑dependent endonuclease inhibitors. It blocks the function of the polymerase acidic protein of influenza viruses, thereby inhibiting viral nucleic acid replication and transcription and rapidly controlling the infection process.

The drug features single‑dose administration, rapid onset of action, and low incidence of drug resistance. It exhibits potent inhibitory activity against both influenza A and B viruses, and is clinically indicated for the treatment of influenza A and B in people aged 12 years and older.

With high safety and convenient administration, GP681 represents a typical domestically developed innovative anti‑influenza drug, providing a new option for clinical influenza treatment.In 2025, global GP681 production reached approximately 1.2 million bottles

GP681 (Suraxavir) is China’s first domestically developed innovative anti-influenza drug targeting the PA protein. With its differentiated advantages of single-dose administration, rapid onset of action and low drug resistance rate, it has entered the domestic anti-influenza drug market worth tens of billions of yuan, breaking the monopoly of foreign products targeting the same site.

Its clinical data are all derived from Chinese populations, providing evidence more suitable for local patients. It demonstrates comparable efficacy and safety to international counterparts, with a significantly lower rate of drug resistance mutations, highlighting its prominent clinical value.

Currently dominated by oseltamivir and baloxavir, the market sees GP681 poised to rapidly penetrate hospital and retail channels and capture share in the PA inhibitor segment, backed by its status as a domestic innovative drug, pricing advantages and expected inclusion in medical insurance.

Meanwhile, the developer is expanding indications for children and high-risk populations and promoting overseas layout, further unlocking market potential and establishing GP681 as a representative breakthrough for domestic innovative drugs in the respiratory field.

This report delivers a comprehensive overview of the global GP681 market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding GP681. The GP681 market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global GP681 market comprehensively. Regional market sizes by Type, by Application, by Target Population, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist GP681 manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of GP681 Market Report

Report Metric	Details
Report Name	GP681 Market
Accounted market size in 2025	US$ 35.00 million
Forecasted market size in 2032	US$ 191 million
CAGR	8.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	20mg / ablet 40mg / ablet
Segment by Target Population	Adolescents Aged 12 Years And Above Adults
Segment by Combination Medication	Combined With Antipyretic And Analgesic Drugs Combined With Mucolytic And Antitussive Drugs
Segment by Sales Channels	Hospitals Retail Online
by Application	Treatment of Influenza A Treatment of Influenza B Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Qingfeng Pharmaceutical, Jiangxi Kerui Pharmaceutical, Yinxingshu Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Target Population, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for GP681 manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines GP681 sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is GP681 Market growing?

Ans: The GP681 Market witnessing a CAGR of 8.1% during the forecast period 2026-2032.

What is the GP681 Market size in 2032?

Ans: The GP681 Market size in 2032 will be US$ 191 million.

Who are the main players in the GP681 Market report?

Ans: The main players in the GP681 Market are Qingfeng Pharmaceutical, Jiangxi Kerui Pharmaceutical, Yinxingshu Pharmaceutical

What are the Application segmentation covered in the GP681 Market report?

Ans: The Applications covered in the GP681 Market report are Treatment of Influenza A, Treatment of Influenza B, Others

What are the Type segmentation covered in the GP681 Market report?

Ans: The Types covered in the GP681 Market report are 20mg / ablet, 40mg / ablet

1 GP681 Market Overview

1.1 Product Definition

1.2 GP681 by Type

1.2.1 Global GP681 Market Value by Type: 2025 vs 2032

1.2.2 20mg / ablet

1.2.3 40mg / ablet

1.3 GP681 by Target Population

1.3.1 Global GP681 Market Value by Target Population: 2025 vs 2032

1.3.2 Adolescents Aged 12 Years And Above

1.3.3 Adults

1.4 GP681 by Combination Medication

1.4.1 Global GP681 Market Value by Combination Medication: 2025 vs 2032

1.4.2 Combined With Antipyretic And Analgesic Drugs

1.4.3 Combined With Mucolytic And Antitussive Drugs

1.5 GP681 by Sales Channels

1.5.1 Global GP681 Market Value by Sales Channels: 2025 vs 2032

1.5.2 Hospitals

1.5.3 Retail

1.5.4 Online

1.6 GP681 by Application

1.6.1 Global GP681 Market Value by Application: 2025 vs 2032

1.6.2 Treatment of Influenza A

1.6.3 Treatment of Influenza B

1.6.4 Others

1.7 Global GP681 Market Size Estimates and Forecasts

1.7.1 Global GP681 Revenue 2021–2032

1.7.2 Global GP681 Sales 2021–2032

1.7.3 Global GP681 Market Average Price (2021–2032)

1.8 Assumptions and Limitations

2 GP681 Market Competition by Manufacturers

2.1 Global GP681 Sales Market Share by Manufacturers (2021–2026)

2.2 Global GP681 Revenue Market Share by Manufacturers (2021–2026)

2.3 Global GP681 Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of GP681, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of GP681, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of GP681, Product Types and Applications

2.7 Global Key Manufacturers of GP681, Date of Entry into the Industry

2.8 Global GP681 Market Competitive Situation and Trends

2.8.1 Global GP681 Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global GP681 Players Market Share by Revenue

2.8.3 Global GP681 Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global GP681 Market Scenario by Region

3.1 Global GP681 Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global GP681 Sales by Region: 2021–2032

3.2.1 Global GP681 Sales by Region: 2021–2026

3.2.2 Global GP681 Sales by Region: 2027–2032

3.3 Global GP681 Revenue by Region: 2021–2032

3.3.1 Global GP681 Revenue by Region: 2021–2026

3.3.2 Global GP681 Revenue by Region: 2027–2032

3.4 North America GP681 Market Facts & Figures by Country

3.4.1 North America GP681 Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America GP681 Sales by Country (2021–2032)

3.4.3 North America GP681 Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe GP681 Market Facts & Figures by Country

3.5.1 Europe GP681 Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe GP681 Sales by Country (2021–2032)

3.5.3 Europe GP681 Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific GP681 Market Facts & Figures by Region

3.6.1 Asia Pacific GP681 Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific GP681 Sales by Region (2021–2032)

3.6.3 Asia Pacific GP681 Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America GP681 Market Facts & Figures by Country

3.7.1 Latin America GP681 Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America GP681 Sales by Country (2021–2032)

3.7.3 Latin America GP681 Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa GP681 Market Facts & Figures by Country

3.8.1 Middle East and Africa GP681 Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa GP681 Sales by Country (2021–2032)

3.8.3 Middle East and Africa GP681 Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global GP681 Sales by Type (2021–2032)

4.1.1 Global GP681 Sales by Type (2021–2026)

4.1.2 Global GP681 Sales by Type (2027–2032)

4.1.3 Global GP681 Sales Market Share by Type (2021–2032)

4.2 Global GP681 Revenue by Type (2021–2032)

4.2.1 Global GP681 Revenue by Type (2021–2026)

4.2.2 Global GP681 Revenue by Type (2027–2032)

4.2.3 Global GP681 Revenue Market Share by Type (2021–2032)

4.3 Global GP681 Price by Type (2021–2032)

5 Segment by Application

5.1 Global GP681 Sales by Application (2021–2032)

5.1.1 Global GP681 Sales by Application (2021–2026)

5.1.2 Global GP681 Sales by Application (2027–2032)

5.1.3 Global GP681 Sales Market Share by Application (2021–2032)

5.2 Global GP681 Revenue by Application (2021–2032)

5.2.1 Global GP681 Revenue by Application (2021–2026)

5.2.2 Global GP681 Revenue by Application (2027–2032)

5.2.3 Global GP681 Revenue Market Share by Application (2021–2032)

5.3 Global GP681 Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Qingfeng Pharmaceutical

6.1.1 Qingfeng Pharmaceutical Company Information

6.1.2 Qingfeng Pharmaceutical Description and Business Overview

6.1.3 Qingfeng Pharmaceutical GP681 Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Qingfeng Pharmaceutical GP681 Product Portfolio

6.1.5 Qingfeng Pharmaceutical Recent Developments/Updates

6.2 Jiangxi Kerui Pharmaceutical

6.2.1 Jiangxi Kerui Pharmaceutical Company Information

6.2.2 Jiangxi Kerui Pharmaceutical Description and Business Overview

6.2.3 Jiangxi Kerui Pharmaceutical GP681 Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Jiangxi Kerui Pharmaceutical GP681 Product Portfolio

6.2.5 Jiangxi Kerui Pharmaceutical Recent Developments/Updates

6.3 Yinxingshu Pharmaceutical

6.3.1 Yinxingshu Pharmaceutical Company Information

6.3.2 Yinxingshu Pharmaceutical Description and Business Overview

6.3.3 Yinxingshu Pharmaceutical GP681 Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Yinxingshu Pharmaceutical GP681 Product Portfolio

6.3.5 Yinxingshu Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 GP681 Industry Chain Analysis

7.2 GP681 Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 GP681 Production Mode & Process Analysis

7.4 GP681 Sales and Marketing

7.4.1 GP681 Sales Channels

7.4.2 GP681 Distributors

7.5 GP681 Customer Analysis

8 GP681 Market Dynamics

8.1 GP681 Industry Trends

8.2 GP681 Market Drivers

8.3 GP681 Market Challenges

8.4 GP681 Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Qingfeng Pharmaceutical

Jiangxi Kerui Pharmaceutical

Yinxingshu Pharmaceutical

List of Tables

Table 1. Global GP681 Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global GP681 Market Value by Target Population (US$ Million), 2025 vs 2032

Table 3. Global GP681 Market Value by Combination Medication (US$ Million), 2025 vs 2032

Table 4. Global GP681 Market Value by Sales Channels (US$ Million), 2025 vs 2032

Table 5. Global GP681 Market Value by Application (US$ Million), 2025 vs 2032

Table 6. Global GP681 Market Competitive Situation by Manufacturers in 2025

Table 7. Global GP681 Sales (Units) of Key Manufacturers (2021–2026)

Table 8. Global GP681 Sales Market Share by Manufacturers (2021–2026)

Table 9. Global GP681 Revenue (US$ Million) by Manufacturers (2021–2026)

Table 10. Global GP681 Revenue Share by Manufacturers (2021–2026)

Table 11. Global Market GP681 Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 12. Global Key Players of GP681, Industry Ranking, 2023 vs 2024 vs 2025

Table 13. Global Key Manufacturers of GP681, Manufacturing Sites and Headquarters

Table 14. Global Key Manufacturers of GP681, Product Types and Applications

Table 15. Global Key Manufacturers of GP681, Date of Entry into the Industry

Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global GP681 Companies by Tier (Tier 1, Tier 2, Tier 3), based on GP681 Revenue, 2025

Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 19. Global GP681 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 20. Global GP681 Sales by Region (Units), 2021–2026

Table 21. Global GP681 Sales Market Share by Region (2021–2026)

Table 22. Global GP681 Sales by Region (Units), 2027–2032

Table 23. Global GP681 Sales Market Share by Region (2027–2032)

Table 24. Global GP681 Revenue by Region (US$ Million), 2021–2026

Table 25. Global GP681 Revenue Market Share by Region (2021–2026)

Table 26. Global GP681 Revenue by Region (US$ Million), 2027–2032

Table 27. Global GP681 Revenue Market Share by Region (2027–2032)

Table 28. North America GP681 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. North America GP681 Sales by Country (Units), 2021–2026

Table 30. North America GP681 Sales by Country (Units), 2027–2032

Table 31. North America GP681 Revenue by Country (US$ Million), 2021–2026

Table 32. North America GP681 Revenue by Country (US$ Million), 2027–2032

Table 33. Europe GP681 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 34. Europe GP681 Sales by Country (Units), 2021–2026

Table 35. Europe GP681 Sales by Country (Units), 2027–2032

Table 36. Europe GP681 Revenue by Country (US$ Million), 2021–2026

Table 37. Europe GP681 Revenue by Country (US$ Million), 2027–2032

Table 38. Asia Pacific GP681 Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 39. Asia Pacific GP681 Sales by Region (Units), 2021–2026

Table 40. Asia Pacific GP681 Sales by Region (Units), 2027–2032

Table 41. Asia Pacific GP681 Revenue by Region (US$ Million), 2021–2026

Table 42. Asia Pacific GP681 Revenue by Region (US$ Million), 2027–2032

Table 43. Latin America GP681 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 44. Latin America GP681 Sales by Country (Units), 2021–2026

Table 45. Latin America GP681 Sales by Country (Units), 2027–2032

Table 46. Latin America GP681 Revenue by Country (US$ Million), 2021–2026

Table 47. Latin America GP681 Revenue by Country (US$ Million), 2027–2032

Table 48. Middle East and Africa GP681 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 49. Middle East and Africa GP681 Sales by Country (Units), 2021–2026

Table 50. Middle East and Africa GP681 Sales by Country (Units), 2027–2032

Table 51. Middle East and Africa GP681 Revenue by Country (US$ Million), 2021–2026

Table 52. Middle East and Africa GP681 Revenue by Country (US$ Million), 2027–2032

Table 53. Global GP681 Sales (Units) by Type (2021–2026)

Table 54. Global GP681 Sales (Units) by Type (2027–2032)

Table 55. Global GP681 Sales Market Share by Type (2021–2026)

Table 56. Global GP681 Sales Market Share by Type (2027–2032)

Table 57. Global GP681 Revenue (US$ Million) by Type (2021–2026)

Table 58. Global GP681 Revenue (US$ Million) by Type (2027–2032)

Table 59. Global GP681 Revenue Market Share by Type (2021–2026)

Table 60. Global GP681 Revenue Market Share by Type (2027–2032)

Table 61. Global GP681 Price (US$/Unit) by Type (2021–2026)

Table 62. Global GP681 Price (US$/Unit) by Type (2027–2032)

Table 63. Global GP681 Sales (Units) by Application (2021–2026)

Table 64. Global GP681 Sales (Units) by Application (2027–2032)

Table 65. Global GP681 Sales Market Share by Application (2021–2026)

Table 66. Global GP681 Sales Market Share by Application (2027–2032)

Table 67. Global GP681 Revenue (US$ Million) by Application (2021–2026)

Table 68. Global GP681 Revenue (US$ Million) by Application (2027–2032)

Table 69. Global GP681 Revenue Market Share by Application (2021–2026)

Table 70. Global GP681 Revenue Market Share by Application (2027–2032)

Table 71. Global GP681 Price (US$/Unit) by Application (2021–2026)

Table 72. Global GP681 Price (US$/Unit) by Application (2027–2032)

Table 73. Qingfeng Pharmaceutical Company Information

Table 74. Qingfeng Pharmaceutical Description and Business Overview

Table 75. Qingfeng Pharmaceutical GP681 Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 76. Qingfeng Pharmaceutical GP681 Product

Table 77. Qingfeng Pharmaceutical Recent Developments/Updates

Table 78. Jiangxi Kerui Pharmaceutical Company Information

Table 79. Jiangxi Kerui Pharmaceutical Description and Business Overview

Table 80. Jiangxi Kerui Pharmaceutical GP681 Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 81. Jiangxi Kerui Pharmaceutical GP681 Product

Table 82. Jiangxi Kerui Pharmaceutical Recent Developments/Updates

Table 83. Yinxingshu Pharmaceutical Company Information

Table 84. Yinxingshu Pharmaceutical Description and Business Overview

Table 85. Yinxingshu Pharmaceutical GP681 Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 86. Yinxingshu Pharmaceutical GP681 Product

Table 87. Yinxingshu Pharmaceutical Recent Developments/Updates

Table 88. Key Raw Materials Lists

Table 89. Raw Materials Key Suppliers Lists

Table 90. GP681 Distributors List

Table 91. GP681 Customers List

Table 92. GP681 Market Trends

Table 93. GP681 Market Drivers

Table 94. GP681 Market Challenges

Table 95. GP681 Market Restraints

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Product Picture of GP681

Figure 2. Global GP681 Market Value by Type (US$ Million), 2021–2032

Figure 3. Global GP681 Market Share by Type: 2025 & 2032

Figure 4. 20mg / ablet Product Picture

Figure 5. 40mg / ablet Product Picture

Figure 6. Global GP681 Market Value by Target Population (US$ Million), 2021–2032

Figure 7. Global GP681 Market Share by Target Population: 2025 vs 2032

Figure 8. Adolescents Aged 12 Years And Above Product Picture

Figure 9. Adults Product Picture

Figure 10. Global GP681 Market Value by Combination Medication (US$ Million), 2021–2032

Figure 11. Global GP681 Market Share by Combination Medication: 2025 vs 2032

Figure 12. Combined With Antipyretic And Analgesic Drugs Product Picture

Figure 13. Combined With Mucolytic And Antitussive Drugs Product Picture

Figure 14. Global GP681 Market Value by Sales Channels (US$ Million), 2021–2032

Figure 15. Global GP681 Market Share by Sales Channels: 2025 vs 2032

Figure 16. Hospitals Product Picture

Figure 17. Retail Product Picture

Figure 18. Online Product Picture

Figure 19. Global GP681 Market Value by Application (US$ Million), 2021–2032

Figure 20. Global GP681 Market Share by Application: 2025 & 2032

Figure 21. Treatment of Influenza A

Figure 22. Treatment of Influenza B

Figure 23. Others

Figure 24. Global GP681 Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 25. Global GP681 Market Size (US$ Million), 2021–2032

Figure 26. Global GP681 Sales (Units), 2021–2032

Figure 27. Global GP681 Average Price (US$/Unit), 2021–2032

Figure 28. GP681 Report Years Considered

Figure 29. GP681 Sales Share by Manufacturers in 2025

Figure 30. Global GP681 Revenue Share by Manufacturers in 2025

Figure 31. Top 5 and Top 10 Global GP681 Players: Market Share by Revenue in GP681 in 2025

Figure 32. GP681 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 33. Global GP681 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 34. North America GP681 Sales Market Share by Country (2021–2032)

Figure 35. North America GP681 Revenue Market Share by Country (2021–2032)

Figure 36. United States GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Canada GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Europe GP681 Sales Market Share by Country (2021–2032)

Figure 39. Europe GP681 Revenue Market Share by Country (2021–2032)

Figure 40. Germany GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. France GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. U.K. GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Italy GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Russia GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Asia Pacific GP681 Sales Market Share by Region (2021–2032)

Figure 46. Asia Pacific GP681 Revenue Market Share by Region (2021–2032)

Figure 47. China GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Japan GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. South Korea GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. India GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Australia GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. China Taiwan GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Southeast Asia GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Latin America GP681 Sales Market Share by Country (2021–2032)

Figure 55. Latin America GP681 Revenue Market Share by Country (2021–2032)

Figure 56. Mexico GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Brazil GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Argentina GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Colombia GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Middle East and Africa GP681 Sales Market Share by Country (2021–2032)

Figure 61. Middle East and Africa GP681 Revenue Market Share by Country (2021–2032)

Figure 62. Turkey GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. Saudi Arabia GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 64. UAE GP681 Revenue Growth Rate (US$ Million), 2021–2032

Figure 65. Global Sales Market Share of GP681 by Type (2021–2032)

Figure 66. Global Revenue Market Share of GP681 by Type (2021–2032)

Figure 67. Global GP681 Price (US$/Unit) by Type (2021–2032)

Figure 68. Global Sales Market Share of GP681 by Application (2021–2032)

Figure 69. Global Revenue Market Share of GP681 by Application (2021–2032)

Figure 70. Global GP681 Price (US$/Unit) by Application (2021–2032)

Figure 71. GP681 Value Chain

Figure 72. Channels of Distribution (Direct Vs Distribution)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions